MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients

Z. Mészáros, D. Borcsiczky, M. Máté, J. Tarcali, K. Tekes, K. Magyar

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In order to study the putative monoamine oxidase (MAO) inhibitory side effect of neuroleptics and simultaneous changes in platelet serotonin content both MAO-B activity and serotonin (5-HT) content in platelets of 30 healthy volunteers and 50 schizophrenic patients treated with neuroleptics were investigated. Our results have shown significantly lower MAO-B activity (15.26 ± 6.81 S.D. vs. 8.63 ± 3.82mmol/hour/109 platelets) and higher platelet 5-HT content (906.19 ± 285.33 vs. 1,727.85 ± 947.40ng/109 platelets) in the schizophrenic group. Platelet MAO-B activity was considerably lower in paranoid and residual schizophrenics compared with other patients, however, no difference was found in platelet 5-HT content between different subtypes of schizophrenia. Various neuroleptic treatments did not produce different effects either on platelet serotonin content or platelet MAO-B activity.

Original languageEnglish
Pages (from-to)79-85
Number of pages7
JournalJournal of Neural Transmission, Supplement
Issue number52
Publication statusPublished - 1998

Fingerprint

Monoamine Oxidase
Antipsychotic Agents
Serotonin
Blood Platelets
Schizophrenia
Healthy Volunteers

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients. / Mészáros, Z.; Borcsiczky, D.; Máté, M.; Tarcali, J.; Tekes, K.; Magyar, K.

In: Journal of Neural Transmission, Supplement, No. 52, 1998, p. 79-85.

Research output: Contribution to journalArticle

@article{88fb3616e130466f9342680e03293d6f,
title = "MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients",
abstract = "In order to study the putative monoamine oxidase (MAO) inhibitory side effect of neuroleptics and simultaneous changes in platelet serotonin content both MAO-B activity and serotonin (5-HT) content in platelets of 30 healthy volunteers and 50 schizophrenic patients treated with neuroleptics were investigated. Our results have shown significantly lower MAO-B activity (15.26 ± 6.81 S.D. vs. 8.63 ± 3.82mmol/hour/109 platelets) and higher platelet 5-HT content (906.19 ± 285.33 vs. 1,727.85 ± 947.40ng/109 platelets) in the schizophrenic group. Platelet MAO-B activity was considerably lower in paranoid and residual schizophrenics compared with other patients, however, no difference was found in platelet 5-HT content between different subtypes of schizophrenia. Various neuroleptic treatments did not produce different effects either on platelet serotonin content or platelet MAO-B activity.",
author = "Z. M{\'e}sz{\'a}ros and D. Borcsiczky and M. M{\'a}t{\'e} and J. Tarcali and K. Tekes and K. Magyar",
year = "1998",
language = "English",
pages = "79--85",
journal = "Journal of Neural Transmission, Supplement",
issn = "0303-6995",
publisher = "Springer Wien",
number = "52",

}

TY - JOUR

T1 - MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients

AU - Mészáros, Z.

AU - Borcsiczky, D.

AU - Máté, M.

AU - Tarcali, J.

AU - Tekes, K.

AU - Magyar, K.

PY - 1998

Y1 - 1998

N2 - In order to study the putative monoamine oxidase (MAO) inhibitory side effect of neuroleptics and simultaneous changes in platelet serotonin content both MAO-B activity and serotonin (5-HT) content in platelets of 30 healthy volunteers and 50 schizophrenic patients treated with neuroleptics were investigated. Our results have shown significantly lower MAO-B activity (15.26 ± 6.81 S.D. vs. 8.63 ± 3.82mmol/hour/109 platelets) and higher platelet 5-HT content (906.19 ± 285.33 vs. 1,727.85 ± 947.40ng/109 platelets) in the schizophrenic group. Platelet MAO-B activity was considerably lower in paranoid and residual schizophrenics compared with other patients, however, no difference was found in platelet 5-HT content between different subtypes of schizophrenia. Various neuroleptic treatments did not produce different effects either on platelet serotonin content or platelet MAO-B activity.

AB - In order to study the putative monoamine oxidase (MAO) inhibitory side effect of neuroleptics and simultaneous changes in platelet serotonin content both MAO-B activity and serotonin (5-HT) content in platelets of 30 healthy volunteers and 50 schizophrenic patients treated with neuroleptics were investigated. Our results have shown significantly lower MAO-B activity (15.26 ± 6.81 S.D. vs. 8.63 ± 3.82mmol/hour/109 platelets) and higher platelet 5-HT content (906.19 ± 285.33 vs. 1,727.85 ± 947.40ng/109 platelets) in the schizophrenic group. Platelet MAO-B activity was considerably lower in paranoid and residual schizophrenics compared with other patients, however, no difference was found in platelet 5-HT content between different subtypes of schizophrenia. Various neuroleptic treatments did not produce different effects either on platelet serotonin content or platelet MAO-B activity.

UR - http://www.scopus.com/inward/record.url?scp=0031596686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031596686&partnerID=8YFLogxK

M3 - Article

SP - 79

EP - 85

JO - Journal of Neural Transmission, Supplement

JF - Journal of Neural Transmission, Supplement

SN - 0303-6995

IS - 52

ER -